DS
SCMP

David Shaw’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

David Shaw’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,363
Closed -$202K – 3653
2017
Q1 		$202K Sell
18,363
-142,196
-89% -$1.65M ﹤0.01% 3118
2016
Q4 		$2.18M Buy
160,559
+58,058
+57% +$810K ﹤0.01% 1932
2016
Q3 		$1.26M Buy
102,501
+75,854
+285% +$894K ﹤0.01% 2244
2016
Q2 		$292K Sell
26,647
-51,444
-66% -$576K ﹤0.01% 3030
2016
Q1 		$854K Buy
78,091
+60,870
+353% +$769K ﹤0.01% 2462
2015
Q4 		$298K Sell
17,221
-160,955
-90% -$2.89M ﹤0.01% 3365
2015
Q3 		$3.54M Buy
178,176
+120,521
+209% +$2.76M 0.01% 1658
2015
Q2 		$947K Buy
57,655
+32,823
+132% +$569K ﹤0.01% 2746
2015
Q1 		$386K Buy
24,832
+8,093
+48% +$125K ﹤0.01% 3191
2014
Q4 		$239K Buy
+16,739
New +$177K ﹤0.01% 3739
2014
Q2 		– Sell
-13,482
Closed -$96K – 4731
2014
Q1 		$96K Sell
13,482
-71,759
-84% -$614K ﹤0.01% 4177
2013
Q4 		$801K Sell
85,241
-18,615
-18% -$133K ﹤0.01% 3356
2013
Q3 		$648K Sell
103,856
-26,273
-20% -$164K ﹤0.01% 3389
2013
Q2 		$856K Buy
+130,129
New +$1.03M ﹤0.01% 2846

Other funds holding SCMP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's SCMP Position: Q2 2017 in Review

David Shaw sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2017, closing a stake of 18,363 shares — an estimated $202K sold.

David Shaw first reported a position in SCMP in Q2 2013 and held it in 14 quarters. The position peaked at $3.54M in Q3 2015. 167 funds tracked by Wall St. Rank hold SCMP as of Q2 2017.

  • David Shaw reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • David Shaw sold 18,363 Sucampo Pharmaceuticals, Inc. shares in Q2 2017, an estimated $202K.
  • David Shaw first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
  • David Shaw's Sucampo Pharmaceuticals, Inc. position peaked at $3.54M in Q3 2015.
  • 167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2017.

Based on D.E. Shaw & Co's 13F filing for Q2 2017, filed 14 Aug 2017.